JCC – Journal of Crohn’s and Colitis
Please login to the ECCO Portal for full access to JCC online (Regular & Y-ECCO Members only)
Laurence J. Egan
National University of Ireland, Galway
JCC Impact Factor 2018: 7.827
The Journal of Crohn's and Colitis (JCC) continually strives to support the IBD community through publication of the best original research, ECCO Guidelines and other articles. JCC is appreciated as a top venue by authors in which to publish their work.
With the publication of the 2018 Impact Factor of 7.827 we now see that the Journal is increasing its impact because our articles are being cited even more frequently than before. With its 2018 Impact Factor, JCC is one of the top journals in the gastroenterology and hepatology field and ranks as the 9th journal.
The increasing impact of the Journal of Crohn's and Colitis is due to the ongoing support of authors and readers, but also reflects the significant advances being made at the moment in most aspects of IBD research and treatment. Let us hope that the increased Impact Factor of our Journal is paralleled by even better outcomes for patients suffering from IBD all over the world in the near future.
The JCC Editor-in-Chief Laurence Egan and the entire Editorial Team thank all ECCO Members, JCC authors, reviewers and readers for their support of JCC.
The Journal of Crohn's and Colitis is the official journal of the European Crohn's and Colitis Organisation (ECCO) and is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to Inflammatory Bowel Diseases (IBD).
The journal publishes original articles, review articles, editorials, ECCO Guidelines, viewpoints, short reports, abstracts and letters to the Editor. JCC is being published every month (12 issues per year) and covers the knowledge and science related to Inflammatory Bowel Diseases: The aims are to update, innovate and challenge.
JCC is defined as an “International Journal”. Although it is the official journal of ECCO, it is open to everyone in the world interested and working in Inflammatory Bowel Diseases.
In 2010, JCC was accepted for MedLine citation, which motivates us – as ECCO – even more to work on the quality and exposure of our journal.